Current Environment: Production

English | Education

Graduate School

California Institute of Technology

1988, Pasadena, CA

Medical School

Yale School of Medicine

1991, New Haven, CT

Internship

Internal Medicine

Beth Israel Deaconess Medical Center

1992, Boston, MA

Residency

Internal Medicine

Beth Israel Deaconess Medical Center

1993, Boston, MA

Fellowship

Infectious Diseases

Massachusetts General Hospital

1995, Boston, MA

English | Publications

  1. The Drosophila G protein-coupled receptor, GulpR, is essential for lipid mobilization in response to nutrient-limitation. bioRxiv. 2025 Apr 23. View The Drosophila G protein-coupled receptor, GulpR, is essential for lipid mobilization in response to nutrient-limitation. Abstract

  2. Carbon source, cell density, and the microbial community control inhibition of V. cholerae surface colonization by environmental nitrate. mBio. 2025 Apr 09; 16(4):e0406624. View Carbon source, cell density, and the microbial community control inhibition of V. cholerae surface colonization by environmental nitrate. Abstract

  3. Carbon source, cell density, and the microbial community control inhibition of V. cholerae surface colonization by environmental nitrate. bioRxiv. 2025 Jan 02. View Carbon source, cell density, and the microbial community control inhibition of V. cholerae surface colonization by environmental nitrate. Abstract

  4. Testosterone treatment impacts the intestinal microbiome of transgender individuals. mSphere. 2024 Oct 29; 9(10):e0055724. View Testosterone treatment impacts the intestinal microbiome of transgender individuals. Abstract

  5. Sequestration of a dual function DNA-binding protein by Vibrio cholerae CRP. Proc Natl Acad Sci U S A. 2022 Nov 16; 119(46):e2210115119. View Sequestration of a dual function DNA-binding protein by Vibrio cholerae CRP. Abstract

  6. Vibrio cholerae high cell density quorum sensing activates the host intestinal innate immune response. Cell Rep. 2022 09 20; 40(12):111368. View Vibrio cholerae high cell density quorum sensing activates the host intestinal innate immune response. Abstract

  7. Bioengineered 3D Tissue Model of Intestine Epithelium with Oxygen Gradients to Sustain Human Gut Microbiome. Adv Healthc Mater. 2022 08; 11(16):e2200447. View Bioengineered 3D Tissue Model of Intestine Epithelium with Oxygen Gradients to Sustain Human Gut Microbiome. Abstract

  8. The Short-Chain Fatty Acids Propionate and Butyrate Augment Adherent-Invasive Escherichia coli Virulence but Repress Inflammation in a Human Intestinal Enteroid Model of Infection. Microbiol Spectr. 2021 10 31; 9(2):e0136921. View The Short-Chain Fatty Acids Propionate and Butyrate Augment Adherent-Invasive Escherichia coli Virulence but Repress Inflammation in a Human Intestinal Enteroid Model of Infection. Abstract

  9. Microbiota-derived acetate activates intestinal innate immunity via the Tip60 histone acetyltransferase complex. Immunity. 2021 08 10; 54(8):1683-1697.e3. View Microbiota-derived acetate activates intestinal innate immunity via the Tip60 histone acetyltransferase complex. Abstract

  10. The Interplay of Sex Steroids, the Immune Response, and the Intestinal Microbiota. Trends Microbiol. 2021 09; 29(9):849-859. View The Interplay of Sex Steroids, the Immune Response, and the Intestinal Microbiota. Abstract

  11. Methionine Availability in the Arthropod Intestine Is Elucidated through Identification of Vibrio cholerae Methionine Acquisition Systems. Appl Environ Microbiol. 2020 05 19; 86(11). View Methionine Availability in the Arthropod Intestine Is Elucidated through Identification of Vibrio cholerae Methionine Acquisition Systems. Abstract

  12. Vibrio cholerae Sheds Its Coat to Make Itself Comfortable in the Gut. Cell Host Microbe. 2020 02 12; 27(2):161-163. View Vibrio cholerae Sheds Its Coat to Make Itself Comfortable in the Gut. Abstract

  13. Microbial Control of Intestinal Homeostasis via Enteroendocrine Cell Innate Immune Signaling. Trends Microbiol. 2020 02; 28(2):141-149. View Microbial Control of Intestinal Homeostasis via Enteroendocrine Cell Innate Immune Signaling. Abstract

  14. A high-throughput, whole cell assay to identify compounds active against carbapenem-resistant Klebsiella pneumoniae. PLoS One. 2018; 13(12):e0209389. View A high-throughput, whole cell assay to identify compounds active against carbapenem-resistant Klebsiella pneumoniae. Abstract

  15. Removal of a Membrane Anchor Reveals the Opposing Regulatory Functions of Vibrio cholerae Glucose-Specific Enzyme IIA in Biofilms and the Mammalian Intestine. mBio. 2018 09 04; 9(5). View Removal of a Membrane Anchor Reveals the Opposing Regulatory Functions of Vibrio cholerae Glucose-Specific Enzyme IIA in Biofilms and the Mammalian Intestine. Abstract

  16. A Self-Assembling Whole-Cell Vaccine Antigen Presentation Platform. J Bacteriol. 2018 08 01; 200(15). View A Self-Assembling Whole-Cell Vaccine Antigen Presentation Platform. Abstract

  17. The Drosophila Immune Deficiency Pathway Modulates Enteroendocrine Function and Host Metabolism. Cell Metab. 2018 09 04; 28(3):449-462.e5. View The Drosophila Immune Deficiency Pathway Modulates Enteroendocrine Function and Host Metabolism. Abstract

  18. Sublingual Adjuvant Delivery by a Live Attenuated Vibrio cholerae-Based Antigen Presentation Platform. mSphere. 2018 06 27; 3(3). View Sublingual Adjuvant Delivery by a Live Attenuated Vibrio cholerae-Based Antigen Presentation Platform. Abstract

  19. Activation of Vibrio cholerae quorum sensing promotes survival of an arthropod host. Nat Microbiol. 2018 02; 3(2):243-252. View Activation of Vibrio cholerae quorum sensing promotes survival of an arthropod host. Abstract

  20. Vibrio cholerae ensures function of host proteins required for virulence through consumption of luminal methionine sulfoxide. PLoS Pathog. 2017 Jun; 13(6):e1006428. View Vibrio cholerae ensures function of host proteins required for virulence through consumption of luminal methionine sulfoxide. Abstract

  21. Erysipelothrix rhusiopathiae Suppurative Arthritis in a 12-year-old Boy After an Unusual Fresh Water Exposure. Pediatr Infect Dis J. 2017 04; 36(4):431-433. View Erysipelothrix rhusiopathiae Suppurative Arthritis in a 12-year-old Boy After an Unusual Fresh Water Exposure. Abstract

  22. The interplay between intestinal bacteria and host metabolism in health and disease: lessons from Drosophila melanogaster. Dis Model Mech. 2016 Mar; 9(3):271-81. View The interplay between intestinal bacteria and host metabolism in health and disease: lessons from Drosophila melanogaster. Abstract

  23. Regulation of CsrB/C sRNA decay by EIIA(Glc) of the phosphoenolpyruvate: carbohydrate phosphotransferase system. Mol Microbiol. 2016 Feb; 99(4):627-39. View Regulation of CsrB/C sRNA decay by EIIA(Glc) of the phosphoenolpyruvate: carbohydrate phosphotransferase system. Abstract

  24. In situ proteolysis of the Vibrio cholerae matrix protein RbmA promotes biofilm recruitment. Proc Natl Acad Sci U S A. 2015 Aug 18; 112(33):10491-6. View In situ proteolysis of the Vibrio cholerae matrix protein RbmA promotes biofilm recruitment. Abstract

  25. The acetate switch of an intestinal pathogen disrupts host insulin signaling and lipid metabolism. Cell Host Microbe. 2014 Nov 12; 16(5):592-604. View The acetate switch of an intestinal pathogen disrupts host insulin signaling and lipid metabolism. Abstract

  26. The transcription factor Mlc promotes Vibrio cholerae biofilm formation through repression of phosphotransferase system components. J Bacteriol. 2014 Jul; 196(13):2423-30. View The transcription factor Mlc promotes Vibrio cholerae biofilm formation through repression of phosphotransferase system components. Abstract

  27. Cholera toxin disrupts barrier function by inhibiting exocyst-mediated trafficking of host proteins to intestinal cell junctions. Cell Host Microbe. 2013 Sep 11; 14(3):294-305. View Cholera toxin disrupts barrier function by inhibiting exocyst-mediated trafficking of host proteins to intestinal cell junctions. Abstract

  28. Mutations in the IMD pathway and mustard counter Vibrio cholerae suppression of intestinal stem cell division in Drosophila. mBio. 2013 Jun 18; 4(3):e00337-13. View Mutations in the IMD pathway and mustard counter Vibrio cholerae suppression of intestinal stem cell division in Drosophila. Abstract

  29. Mannitol and the mannitol-specific enzyme IIB subunit activate Vibrio cholerae biofilm formation. Appl Environ Microbiol. 2013 Aug; 79(15):4675-83. View Mannitol and the mannitol-specific enzyme IIB subunit activate Vibrio cholerae biofilm formation. Abstract

  30. Glucose-specific enzyme IIA has unique binding partners in the vibrio cholerae biofilm. mBio. 2012 Nov 06; 3(6):e00228-12. View Glucose-specific enzyme IIA has unique binding partners in the vibrio cholerae biofilm. Abstract

  31. The bacterial biofilm matrix as a platform for protein delivery. mBio. 2012; 3(4):e00127-12. View The bacterial biofilm matrix as a platform for protein delivery. Abstract

  32. The Drosophila protein mustard tailors the innate immune response activated by the immune deficiency pathway. J Immunol. 2012 Apr 15; 188(8):3993-4000. View The Drosophila protein mustard tailors the innate immune response activated by the immune deficiency pathway. Abstract

  33. A high-throughput screen identifies a new natural product with broad-spectrum antibacterial activity. PLoS One. 2012; 7(2):e31307. View A high-throughput screen identifies a new natural product with broad-spectrum antibacterial activity. Abstract

  34. Spatially selective colonization of the arthropod intestine through activation of Vibrio cholerae biofilm formation. Proc Natl Acad Sci U S A. 2011 Dec 06; 108(49):19737-42. View Spatially selective colonization of the arthropod intestine through activation of Vibrio cholerae biofilm formation. Abstract

  35. A communal bacterial adhesin anchors biofilm and bystander cells to surfaces. PLoS Pathog. 2011 Aug; 7(8):e1002210. View A communal bacterial adhesin anchors biofilm and bystander cells to surfaces. Abstract

  36. The phosphoenolpyruvate phosphotransferase system regulates Vibrio cholerae biofilm formation through multiple independent pathways. J Bacteriol. 2010 Jun; 192(12):3055-67. View The phosphoenolpyruvate phosphotransferase system regulates Vibrio cholerae biofilm formation through multiple independent pathways. Abstract

  37. Vibrio cholerae phosphoenolpyruvate phosphotransferase system control of carbohydrate transport, biofilm formation, and colonization of the germfree mouse intestine. Infect Immun. 2010 Apr; 78(4):1482-94. View Vibrio cholerae phosphoenolpyruvate phosphotransferase system control of carbohydrate transport, biofilm formation, and colonization of the germfree mouse intestine. Abstract

  38. Signals, regulatory networks, and materials that build and break bacterial biofilms. Microbiol Mol Biol Rev. 2009 Jun; 73(2):310-47. View Signals, regulatory networks, and materials that build and break bacterial biofilms. Abstract

  39. Genetic analysis of Drosophila melanogaster susceptibility to intestinal Vibrio cholerae infection. Cell Microbiol. 2009 Mar; 11(3):461-74. View Genetic analysis of Drosophila melanogaster susceptibility to intestinal Vibrio cholerae infection. Abstract

  40. Genetic analysis of Vibrio cholerae monolayer formation reveals a key role for DeltaPsi in the transition to permanent attachment. J Bacteriol. 2008 Dec; 190(24):8185-96. View Genetic analysis of Vibrio cholerae monolayer formation reveals a key role for DeltaPsi in the transition to permanent attachment. Abstract

  41. A novel role for enzyme I of the Vibrio cholerae phosphoenolpyruvate phosphotransferase system in regulation of growth in a biofilm. J Bacteriol. 2008 Jan; 190(1):311-20. View A novel role for enzyme I of the Vibrio cholerae phosphoenolpyruvate phosphotransferase system in regulation of growth in a biofilm. Abstract

  42. NspS, a predicted polyamine sensor, mediates activation of Vibrio cholerae biofilm formation by norspermidine. J Bacteriol. 2005 Nov; 187(21):7434-43. View NspS, a predicted polyamine sensor, mediates activation of Vibrio cholerae biofilm formation by norspermidine. Abstract

  43. Vibrio cholerae infection of Drosophila melanogaster mimics the human disease cholera. PLoS Pathog. 2005 Sep; 1(1):e8. View Vibrio cholerae infection of Drosophila melanogaster mimics the human disease cholera. Abstract

  44. Identification of novel stage-specific genetic requirements through whole genome transcription profiling of Vibrio cholerae biofilm development. Mol Microbiol. 2005 Sep; 57(6):1623-35. View Identification of novel stage-specific genetic requirements through whole genome transcription profiling of Vibrio cholerae biofilm development. Abstract

  45. Role for glycine betaine transport in Vibrio cholerae osmoadaptation and biofilm formation within microbial communities. Appl Environ Microbiol. 2005 Jul; 71(7):3840-7. View Role for glycine betaine transport in Vibrio cholerae osmoadaptation and biofilm formation within microbial communities. Abstract

  46. Genetic evidence that the Vibrio cholerae monolayer is a distinct stage in biofilm development. Mol Microbiol. 2004 Apr; 52(2):573-87. View Genetic evidence that the Vibrio cholerae monolayer is a distinct stage in biofilm development. Abstract

  47. The Vibrio cholerae O139 O-antigen polysaccharide is essential for Ca2+-dependent biofilm development in sea water. Proc Natl Acad Sci U S A. 2003 Nov 25; 100(24):14357-62. View The Vibrio cholerae O139 O-antigen polysaccharide is essential for Ca2+-dependent biofilm development in sea water. Abstract

  48. Role of ectoine in Vibrio cholerae osmoadaptation. Appl Environ Microbiol. 2003 Oct; 69(10):5919-27. View Role of ectoine in Vibrio cholerae osmoadaptation. Abstract

  49. Environmental determinants of Vibrio cholerae biofilm development. Appl Environ Microbiol. 2003 Sep; 69(9):5079-88. View Environmental determinants of Vibrio cholerae biofilm development. Abstract

  50. Identification and characterization of a Vibrio cholerae gene, mbaA, involved in maintenance of biofilm architecture. J Bacteriol. 2003 Feb; 185(4):1384-90. View Identification and characterization of a Vibrio cholerae gene, mbaA, involved in maintenance of biofilm architecture. Abstract

  51. Vibrio cholerae CytR is a repressor of biofilm development. Mol Microbiol. 2002 Jul; 45(2):471-83. View Vibrio cholerae CytR is a repressor of biofilm development. Abstract

  52. Paula I Watnick--elucidating the role of biofilms. Interview by Pam Das. Lancet Infect Dis. 2002 Mar; 2(3):190-2. View Paula I Watnick--elucidating the role of biofilms. Interview by Pam Das. Abstract

  53. The absence of a flagellum leads to altered colony morphology, biofilm development and virulence in Vibrio cholerae O139. Mol Microbiol. 2001 Jan; 39(2):223-35. View The absence of a flagellum leads to altered colony morphology, biofilm development and virulence in Vibrio cholerae O139. Abstract

  54. Biofilm, city of microbes. J Bacteriol. 2000 May; 182(10):2675-9. View Biofilm, city of microbes. Abstract

  55. Vibrio cholerae VibF is required for vibriobactin synthesis and is a member of the family of nonribosomal peptide synthetases. J Bacteriol. 2000 Mar; 182(6):1731-8. View Vibrio cholerae VibF is required for vibriobactin synthesis and is a member of the family of nonribosomal peptide synthetases. Abstract

  56. Steps in the development of a Vibrio cholerae El Tor biofilm. Mol Microbiol. 1999 Nov; 34(3):586-95. View Steps in the development of a Vibrio cholerae El Tor biofilm. Abstract

  57. A role for the mannose-sensitive hemagglutinin in biofilm formation by Vibrio cholerae El Tor. J Bacteriol. 1999 Jun; 181(11):3606-9. View A role for the mannose-sensitive hemagglutinin in biofilm formation by Vibrio cholerae El Tor. Abstract

  58. Genetic approaches to study of biofilms. Methods Enzymol. 1999; 310:91-109. View Genetic approaches to study of biofilms. Abstract

  59. The interaction of the Vibrio cholerae transcription factors, Fur and IrgB, with the overlapping promoters of two virulence genes, irgA and irgB. Gene. 1998 Mar 16; 209(1-2):65-70. View The interaction of the Vibrio cholerae transcription factors, Fur and IrgB, with the overlapping promoters of two virulence genes, irgA and irgB. Abstract

  60. Purification of Vibrio cholerae fur and estimation of its intracellular abundance by antibody sandwich enzyme-linked immunosorbent assay. J Bacteriol. 1997 Jan; 179(1):243-7. View Purification of Vibrio cholerae fur and estimation of its intracellular abundance by antibody sandwich enzyme-linked immunosorbent assay. Abstract

  61. Hydrophobic mismatch in gramicidin A'/lecithin systems. Biochemistry. 1990 Jul 03; 29(26):6215-21. View Hydrophobic mismatch in gramicidin A'/lecithin systems. Abstract

  62. Characterization of the transverse relaxation rates in lipid bilayers. Proc Natl Acad Sci U S A. 1990 Mar; 87(6):2082-6. View Characterization of the transverse relaxation rates in lipid bilayers. Abstract

  63. Conformations of model peptides in membrane-mimetic environments. Biophys J. 1982 Jan; 37(1):275-84. View Conformations of model peptides in membrane-mimetic environments. Abstract

English | Education

Medical School

Duke University

1979, Durham

Internship

Internal Medicine

Beth Israel Deaconess Medical Center

1980, Boston, MA

Residency

Internal Medicine

Beth Israel Deaconess Medical Center

1982, Boston, MA

Fellowship

Beth Israel Deaconess Medical Center

1982, Boston, MA

Fellowship

Infectious Diseases

Brigham & Women's Hospital/Beth Israel Deaconess Medical Center

1985, Boston, MA

English | Publications

English | Education

Medical School

Temple University School of Medicine

2003, Philadelphia, PA

Internship

Dartmouth Hitchcock Memorial Hospital

2006, Lebanon, NH

Fellowship

St. Jude Children's Research Hospital

2010, Memphis, TN

English | Publications

English | Education

Undergraduate School

Bachelor of Science

University of North Carolina

Chapel Hill, NC

Graduate School

Biological Sciences

University of California, San Francisco

San Francisco, CA

Medical School

University of California, Los Angeles

Los Angeles, CA

Internship

Pediatrics

Boston Children's Hospital/Boston Medical Center

Boston, MA

Residency

Pediatrics

Boston Children's Hospital/Boston Medical Center

Boston, MA

Fellowship

Pediatric Hematology -Oncology

Boston Children's Hospital/Dana-Farber Cancer Institute

English | Publications

English | Education

Undergraduate School

Tufts University

1987, Medford, MA

Medical School

University of Pennsylvania

1993, Philadelphia, PA

Internship

Floating Hospital for Children

1994, Boston, MA

Residency

Floating Hospital for Children

1997, Boston, MA

English | Education

Undergraduate School

Cornell University

Ithaca, NY

Graduate School

Boston University

Boston, MA

Medical School

Georgetown Medical School

Washington, DC

Internship

Pediatrics

Brown Medical School

Providence, RI

Residency

Pediatrics

Brown Medical School

Providence, RI

Fellowship

Pediatrics

Boston University General Academic

Boston, MA

English | Publications

Talk to Lesley

If this is a medical emergency, please dial 9-1-1. This application should not be used in an emergency. This chat is being transmitted via a secure connection.

Hi! My name is Lesley. I am a virtual agent programmed to help you. If you would like to speak to a live agent, please call 617-355-6000.

I am unable to answer specific questions regarding your child's case, including appointments and conditions/diagnosis. Please contact your physician's office.

Quick links:

- MyChildrens Portal
- Global Services
- Find a Doctor
- Find a Location
- Programs and Services